Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction

Cardiovascular complications are the most prevalent cause of morbidity and mortality in diabetic patients. Metformin is currently the first-line blood glucose-lowering agent with potential relevance to cardiovascular diseases. However, the underpinning mechanisms of action remain elusive. Here, we r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Loi, Halyna, Boal, Frederic, Tronchere, Helene, Cinato, Mathieu, Kramar, Solomiia, Oleshchuk, Oleksandra, Korda, Mykhaylo, Kunduzova, Oksana
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400884/
https://ncbi.nlm.nih.gov/pubmed/30873028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00154
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares